Skip to main content

Capture of Long COVID in TriNetX: A Descriptive Analysis

    Basic Details
    Date Posted
    Health Outcome(s)
    post-acute COVID-19 syndrome

    In this report, we characterized two cohorts; one indexing on acute Coronavirus Disease (COVID) diagnosis or positive Severe Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) test, and a second cohort indexing on Long COVID. These analyses are intended as an exploration of the FDA's Sentinel Electronic Health Record (EHR) data sources (specifically TriNetX) to capture Long COVID and assess feasibility of future Long COVID studies in TriNetX.

    The study period includes data from January 1, 2021 to February 23, 2023 and contains data from 34 health care organizations (HCOs), provided through the TriNetX Live™ platform in their USA with No Shift Network. The query was run on March 29, 2023.

    Additional Details
    FDA Center
    Time Period
    January 1, 2021 – February 23, 2023
    Analysis Type
    TriNetX Analysis
    Population / Cohort
    All individuals
    Data Sources
    TriNetX USA with No Shift Network